Phase I metabolic profiling and unexpected reactive metabolites in human liver microsome incubations of X-376 using LC-MS/MS: bioactivation pathway elucidation and in silico toxicity studies of its metabolites

X-376 is a novel new generation anaplastic lymphoma kinase (ALK) inhibitor that can cross the blood brain barrier, so it can be used in patients with both ALK-positive NSCLC with CNS metastases. In this study, X-376 was incubated with human liver microsomes, and in vitro phase-I metabolic reactions...

Descripción completa

Detalles Bibliográficos
Autores principales: Attwa, Mohamed W., Kadi, Adnan A., Abdelhameed, Ali S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2020
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9049494/
https://www.ncbi.nlm.nih.gov/pubmed/35498318
http://dx.doi.org/10.1039/c9ra09115g

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9049494/
https://www.ncbi.nlm.nih.gov/pubmed/35498318
http://dx.doi.org/10.1039/c9ra09115g

Ejemplares similares